Immutrix Therapeutics
Rapid City
About Immutrix Therapeutics
Immutrix Therapeutics s is a medical tech company that develops and markets blood cleansing treatment device. The company's product removes inflammatory mediators and toxins from blood using proprietary adsorbents and smart hollow fiber membranes. Immutrix products target and bind molecules (modifiers) of interest in a "dialysis-like" procedure to treat a broad range of medical conditions. The modifiers to be removed are those molecules which cause an undesired immune or pathological response, often referred to as mediators. The company was incorporated in 2009 and is based in Rapid City, South Dakota.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $12.6M
- Last round: Debt Financing (Sep 2025)
- Website: immutrix.com
- Phone: (605)721-7979
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Therapeutics
Canonical: https://fsome.com/organization/immutrix-therapeutics-28210 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.